High-dimensional biomarker identification for interpretable disease prediction via machine learning models
Bioinformatics · 06.05.2025 · 41 (5)
DOI: 10.1093/bioinformatics/btaf266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 26.04.2025. Verfasst von Yifan Dai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States. Hauptthemen laut MEDLINE: Machine Learning, Biomarkers, Computational Biology. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NLM NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Motivation Omics features, often measured by high-throughput technologies, combined with clinical features, significantly impact the understanding of many complex human diseases. Integrating key omics biomarkers with clinical risk factors is essential for elucidating disease mechanisms, advancing early diagnosis, and enhancing precision medicine. However, the high dimensionality and intricate associations between disease outcomes and omics profiles present substantial analytical challenges. Results We propose a high-dimensional feature importance test (HiFIT) framework to address these challenges. Specifically, we develop an ensemble data-driven biomarker identification tool, Hybrid Feature Screening (HFS), to construct a candidate feature set for downstream machine learning models. The pre-screened candidate features from HFS are further refined using a computationally efficient permutation-based feature importance test employing machine learning methods to flexibly model the potential complex associations between disease outcomes and molecular biomarkers. Through extensive numerical simulation studies and practical applications to microbiome-associated weight changes following bariatric surgery, as well as the examination of gene-expression-associated kidney pan-cancer survival data, we demonstrate HiFIT’s superior performance in both outcome prediction and feature importance identification. Availability and implementation An R package implementing the HiFIT algorithm is available on GitHub (https://github.com/BZou-lab/HiFIT).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
ORCID-Profile: Yifan Dai, Di Wu, Ian Carroll, Fei Zou, Baiming Zou
Förderung
- NLM NIH HHS
- NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Dai, Y., Wu, D., Carroll, I., Zou, F., & Zou, B. (2025). High-dimensional biomarker identification for interpretable disease prediction via machine learning models. Bioinformatics, 41(5). https://doi.org/10.1093/bioinformatics/btaf266
Vancouver
Dai Y, Wu D, Carroll I, Zou F, Zou B. High-dimensional biomarker identification for interpretable disease prediction via machine learning models. Bioinformatics. 2025;41(5). doi:10.1093/bioinformatics/btaf266
BibTeX
@article{Dai2025,
author = {Dai, Yifan and Wu, Di and Carroll, Ian and Zou, Fei and Zou, Baiming},
title = {High-dimensional biomarker identification for interpretable disease prediction via machine learning models},
journal = {Bioinformatics},
year = {2025},
volume = {41},
number = {5},
doi = {10.1093/bioinformatics/btaf266}
}
EUVIMED